Mirae Asset Global Etfs Holdings Ltd. Harvard Bioscience Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 25,324 shares of HBIO stock, worth $11,902. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,324
Previous 24,310
4.17%
Holding current value
$11,902
Previous $51,000
72.55%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding HBIO
# of Institutions
96Shares Held
26.2MCall Options Held
8.7KPut Options Held
2K-
Amh Equity LTD3.39MShares$1.59 Million3.14% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$1.34 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.19MShares$1.03 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.14MShares$1.01 Million0.0% of portfolio
-
Royce & Associates LP1.78MShares$835,6100.01% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $19.6M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...